Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Aortic Diseases

imatinib mesylate has been researched along with Aortic Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ali, R; Geirsson, A; Greif, DM; Humphrey, JD; Jiao, Y; Li, G; Li, Q; Li, W; Qin, L; Qyang, Y; Tellides, G1
Aaltola, EM; Buchdunger, E; Koskinen, PK; Krebs, R; Laitinen, O; Lemström, KB; Sihvola, RK; Tikkanen, JM1
Allen, TJ; Candido, R; Cao, Z; Cooper, ME; Jandeleit-Dahm, KA; Lassila, M; Thallas, V1

Other Studies

3 other study(ies) available for imatinib mesylate and Aortic Diseases

ArticleYear
mTOR (Mechanistic Target of Rapamycin) Inhibition Decreases Mechanosignaling, Collagen Accumulation, and Stiffening of the Thoracic Aorta in Elastin-Deficient Mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2017, Volume: 37, Issue:9

    Topics: Animals; Aorta, Thoracic; Aortic Diseases; Cell Proliferation; Collagen; Elastin; Everolimus; Focal Adhesion Kinase 1; Genetic Predisposition to Disease; Humans; Imatinib Mesylate; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mechanotransduction, Cellular; Mice, Inbred C57BL; Mice, Knockout; Multiprotein Complexes; Muscle, Smooth, Vascular; Phenotype; Phosphorylation; Protein Kinase Inhibitors; Sirolimus; Time Factors; TOR Serine-Threonine Kinases; Vascular Stiffness; Williams Syndrome

2017
Platelet-derived growth factor receptor inhibition reduces allograft arteriosclerosis of heart and aorta in cholesterol-fed rabbits.
    Transplantation, 2003, Feb-15, Volume: 75, Issue:3

    Topics: Animals; Antineoplastic Agents; Aorta, Thoracic; Aortic Diseases; Benzamides; Cholesterol, Dietary; Coronary Artery Disease; Female; Graft Survival; Heart Transplantation; Hypercholesterolemia; Imatinib Mesylate; Incidence; Macrophages; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Rabbits; Receptors, Platelet-Derived Growth Factor; Transplantation, Homologous

2003
Imatinib attenuates diabetes-associated atherosclerosis.
    Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:5

    Topics: Animals; Aorta; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Benzamides; Cytokines; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Drug Evaluation, Preclinical; Enzyme Inhibitors; Genes, abl; Genes, sis; Glycated Hemoglobin; Imatinib Mesylate; Intercellular Signaling Peptides and Proteins; Lipids; Male; Mice; Mice, Knockout; Organometallic Compounds; Peptides; Piperazines; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-sis; Pyrimidines; Random Allocation; Receptor, Platelet-Derived Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction; Streptozocin; Systole; Vascular Cell Adhesion Molecule-1

2004